{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:19:11Z","timestamp":1773087551214,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902907"],"award-info":[{"award-number":["81902907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1245\/s10434-022-12598-7","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T21:23:03Z","timestamp":1663968183000},"page":"363-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis"],"prefix":"10.1245","volume":"30","author":[{"given":"Long-Hai","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ti","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Rong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ming","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"issue":"5","key":"12598_CR1","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1245\/s10434-019-07227-9","volume":"26","author":"DJ Erstad","year":"2019","unstructured":"Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol. 2019;26(5):1474\u201393. https:\/\/doi.org\/10.1245\/s10434-019-07227-9.","journal-title":"Ann Surg Oncol."},{"key":"12598_CR2","doi-asserted-by":"publisher","first-page":"9567041","DOI":"10.1155\/2022\/9567041","volume":"2022","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Guan R, Jianxi W, et al. Microvascular invasion in hepatocellular carcinoma: a review of its definition, clinical significance, and comprehensive management. J Oncol. 2022;2022:9567041.","journal-title":"J Oncol."},{"issue":"3","key":"12598_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.ejso.2020.10.039","volume":"47","author":"LH Feng","year":"2021","unstructured":"Feng LH, Sun HC, Zhu XD, et al. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy. Eur J Surg Oncol. 2021;47(3):681\u20139.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"12598_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/hepr.13241","volume":"49","author":"H Wang","year":"2019","unstructured":"Wang H, Wu MC, Cong WM. Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis. Hepatol Res. 2019;49(3):344\u201354.","journal-title":"Hepatol Res."},{"issue":"4","key":"12598_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.12.025","volume":"220","author":"VG Agopian","year":"2015","unstructured":"Agopian VG, Harlander-Locke M, Zarrinpar A, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg. 2015;220(4):416\u201327.","journal-title":"J Am Coll Surg."},{"issue":"4","key":"12598_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/lt.21078","volume":"13","author":"JR Parfitt","year":"2007","unstructured":"Parfitt JR, Marotta P, Alghamdi M, et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl. 2007;13(4):543\u201351.","journal-title":"Liver Transpl."},{"issue":"42","key":"12598_CR7","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.3748\/wjg.v22.i42.9279","volume":"22","author":"WM Cong","year":"2016","unstructured":"Cong WM, Bu H, Chen J, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol. 2016;22(42):9279\u201387.","journal-title":"World J Gastroenterol."},{"issue":"4","key":"12598_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","volume":"151","author":"Z Lei","year":"2016","unstructured":"Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis b virus-related hepatocellular carcinoma within the milan criteria. JAMA Surg. 2016;151(4):356\u201363.","journal-title":"JAMA Surg."},{"key":"12598_CR9","doi-asserted-by":"publisher","first-page":"831996","DOI":"10.3389\/fonc.2022.831996","volume":"12","author":"L Li","year":"2022","unstructured":"Li L, Wu C, Huang Y, Chen J, Ye D, Su Z. Radiomics for the preoperative evaluation of microvascular invasion in hepatocellular carcinoma: a meta-analysis. Front Oncol. 2022;12:831996.","journal-title":"Front Oncol."},{"issue":"8","key":"12598_CR10","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s00259-020-05119-9","volume":"48","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang Y, Fang Q, et al. Radiomics analysis of [(18)F]FDG PET\/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2021;48(8):2599\u2013614.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"6","key":"12598_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","volume":"70","author":"X Xu","year":"2019","unstructured":"Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70(6):1133\u201344.","journal-title":"J Hepatol."},{"issue":"3","key":"12598_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/SLA.0000000000003268","volume":"273","author":"S Lee","year":"2021","unstructured":"Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564\u201371.","journal-title":"Ann Surg."},{"issue":"6","key":"12598_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/liv.12459","volume":"34","author":"K Shirabe","year":"2014","unstructured":"Shirabe K, Toshima T, Kimura K, et al. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma. Liver Int. 2014;34(6):937\u201341.","journal-title":"Liver Int."},{"issue":"2","key":"12598_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00432-016-2286-1","volume":"143","author":"LH Feng","year":"2017","unstructured":"Feng LH, Dong H, Lau WY, et al. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143(2):293\u2013303.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"3","key":"12598_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","volume":"137","author":"S Roayaie","year":"2009","unstructured":"Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137(3):850\u20135.","journal-title":"Gastroenterology."},{"issue":"3","key":"12598_CR16","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1245\/s10434-013-3376-9","volume":"21","author":"S Sumie","year":"2014","unstructured":"Sumie S, Nakashima O, Okuda K, et al. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma. Ann Surg Oncol. 2014;21(3):1002\u20139. https:\/\/doi.org\/10.1245\/s10434-013-3376-9.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"12598_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1097\/TP.0000000000000489","volume":"99","author":"T Iguchi","year":"2015","unstructured":"Iguchi T, Shirabe K, Aishima S, et al. New pathologic stratification of microvascular invasion in hepatocellular carcinoma: predicting prognosis after living-donor liver transplantation. Transplantation. 2015;99(6):1236\u201342.","journal-title":"Transplantation."},{"issue":"3","key":"12598_CR18","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.18632\/oncotarget.12547","volume":"8","author":"H Zhao","year":"2017","unstructured":"Zhao H, Chen C, Fu X, et al. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection. Oncotarget. 2017;8(3):5474\u201386.","journal-title":"Oncotarget."},{"key":"12598_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.ejso.2021.12.466","volume":"48","author":"K Wang","year":"2021","unstructured":"Wang K, Xiang YJ, Yu HM, et al. A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion. Eur J Surg Oncol. 2021;48:1348\u201355.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"12598_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s12072-021-10174-x","volume":"15","author":"ZH Chen","year":"2021","unstructured":"Chen ZH, Zhang XP, Feng JK, et al. Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China. Hepatol Int. 2021;15(3):642\u201350.","journal-title":"Hepatol Int."},{"issue":"9959","key":"12598_CR21","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053\u201363.","journal-title":"Lancet."},{"issue":"4","key":"12598_CR22","first-page":"195","volume":"6","author":"TL Wang","year":"1998","unstructured":"Wang TL, Liu X, Zhou YP, He JW, Zhang J, Li NZ, Duan ZP, Wang BE. A semiquantitative scoring system for assessment of hepatic inflammation and fibrosis in chronic viral hepatitis. Chin J Hepatol. 1998;6(4):195\u20137.","journal-title":"Chin J Hepatol."},{"issue":"5","key":"12598_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jhep.2007.06.019","volume":"47","author":"HC Sun","year":"2007","unstructured":"Sun HC, Zhang W, Qin LX, et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol. 2007;47(5):684\u201390.","journal-title":"J Hepatol."},{"issue":"5","key":"12598_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.gastro.2013.01.021","volume":"144","author":"Y Hoshida","year":"2013","unstructured":"Hoshida Y, Villanueva A, Sangiovanni A, et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013;144(5):1024\u201330.","journal-title":"Gastroenterology."},{"key":"12598_CR25","unstructured":"https:\/\/www.medcalc.org\/index.php. Accessed 4 March 2020."},{"key":"12598_CR26","unstructured":"http:\/\/www.r-project.org\/. Accessed 30 November 2021."},{"key":"12598_CR27","unstructured":"https:\/\/cran.rstudio.com\/web\/packages\/rpart\/index.html. Accessed 21 January 2022."},{"key":"12598_CR28","unstructured":"https:\/\/cran.rstudio.com\/web\/packages\/timeROC\/index.html. Accessed 18 December 2019."},{"issue":"5","key":"12598_CR29","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1245\/s10434-008-9846-9","volume":"15","author":"S Sumie","year":"2008","unstructured":"Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15(5):1375\u201382. https:\/\/doi.org\/10.1245\/s10434-008-9846-9.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"12598_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.21037\/hbsn-20-480","volume":"9","author":"DY Xie","year":"2020","unstructured":"Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9(4):452\u201363.","journal-title":"Hepatobiliary Surg Nutr."},{"key":"12598_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13027-020-0273-2","volume":"15","author":"X Xue","year":"2020","unstructured":"Xue X, Liao W, Xing Y. Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma. Infect Agent Cancer. 2020;15:11.","journal-title":"Infect Agent Cancer."},{"issue":"1","key":"12598_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.35772\/ghm.019.01018","volume":"1","author":"N Kokudo","year":"2019","unstructured":"Kokudo N, Takemura N, Kanto T, Tateishi R, Igari T, Hasegawa K. Hepatocellular carcinoma with non-B and non-C hepatitis origin: epidemiology in Japan and surgical outcome. Glob Health Med. 2019;1(1):23\u20139.","journal-title":"Glob Health Med."},{"issue":"3","key":"12598_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/SLA.0000000000000821","volume":"261","author":"T Utsunomiya","year":"2015","unstructured":"Utsunomiya T, Shimada M, Kudo M, et al. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg. 2015;261(3):513\u201320.","journal-title":"Ann Surg."},{"key":"12598_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00620-y","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022. https:\/\/doi.org\/10.1038\/s41575-022-00620-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"12598_CR35","doi-asserted-by":"publisher","first-page":"782","DOI":"10.21037\/hbsn-19-810","volume":"10","author":"WY Lau","year":"2021","unstructured":"Lau WY, Wang K, Zhang XP, et al. A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus. Hepatobiliary Surg Nutr. 2021;10(6):782\u201395.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"5","key":"12598_CR36","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/hep.31992","volume":"74","author":"TC Wong","year":"2021","unstructured":"Wong TC, Lee VH, Law AL, et al. Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant. Hepatology. 2021;74(5):2580\u201394.","journal-title":"Hepatology."},{"issue":"6","key":"12598_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21037\/hbsn.2019.10.26","volume":"9","author":"A Chotirosniramit","year":"2020","unstructured":"Chotirosniramit A, Liwattanakun A, Junrungsee S, Ko-Iam W, Sandhu T, Lapisatepun W. The benefit of curative liver resection with a selective bile duct preserving approach for hepatocellular carcinoma with macroscopic bile duct tumor thrombus. Hepatobiliary Surg Nutr. 2020;9(6):729\u201338.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"2","key":"12598_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaoncol.2019.4477","volume":"6","author":"Y Xia","year":"2020","unstructured":"Xia Y, Li J, Liu G, et al. Long-term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among patients with recurrent hepatocellular carcinoma: a randomized clinical trial. JAMA Oncol. 2020;6(2):255\u201363.","journal-title":"JAMA Oncol."},{"issue":"3","key":"12598_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000488035","volume":"7","author":"J Zhou","year":"2018","unstructured":"Zhou J, Sun HC, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China. Liver Cancer. 2018;7(3):235\u201360.","journal-title":"Liver Cancer."},{"issue":"3","key":"12598_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76(3):681\u201393.","journal-title":"J Hepatol."},{"issue":"4","key":"12598_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey JN. 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845\u20137. https:\/\/doi.org\/10.1245\/s10434-017-6025-x.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12598-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12598-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12598-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:23:43Z","timestamp":1670347423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12598-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["12598"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12598-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interests related to this publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}